A 3-year-old girl who presented with anemia, thrombocytopenia, and recurrent strokes is described. The cerebral angiography revealed moyamoya vasculopathy. Her younger brother also had anemia and thrombocytopenia but no neurologic abnormalities. Both children had severe deficiency of ADAMTS13 (A Disintegrin And Metalloprotease with Thrombospondin like domain activity) confirming the diagnosis of congenital thrombotic thrombocytopenic purpura. The children responded well to regular fresh-frozen plasma infusions. This report expands the spectrum of hematologic diseases associated with moyamoya syndrome. Unexplained thrombocytopenia, especially in the presence of neurologic symptoms, should prompt an evaluation for ADAMTS13deficiency. The diagnosis has significant implications not only for therapy but also for genetic counseling.
HortonTMStoneJDYeeDDreyerZMoakeJLMahoneyDH. Case series of thrombotic thrombocytopenic purpura in children and adolescents. J Pediatr Hematol Oncol. 2003;25:336–339.
2.
CurtilletCPoullinPDoréEPediatric case report of an acquired autoimmune thrombotic thrombocytopenic purpura. Arch Pediatr. 2006;13:1521–1524.
3.
LottaLAGaragiolaIPallaRCairoAPeyvandiF. ADAMTS13 mutations and polymorphisms in congenital thrombotic thrombocytopenic purpura. Hum Mutat. 2010;31:11–19.
4.
LevyGGNicholsWCLianECMutations in a member of the ADAMTS 13 gene family cause thrombotic thrombocytopenic purpura. Nature. 2001;413:488–494.
5.
LoiratCGirmaJPDesconcloisCCoppoPVeyradierA. Thrombotic thrombocytopenic purpura related to severe ADAMTS13 deficiency in children. Pediatr Nephrol. 2009;24:19–29.
6.
MoakeJL. Von Willebrand factor, ADAMTS13 and thrombotic thrombocytopenic purpura. Semin Hematol. 2004;41:4–14.
7.
LoiratCVeyradierAGirmaJPRibbaASMeyerD. Thrombotic thrombocytopenic purpura associated with von Willebrand factor-cleaving protease (ADAMTS13) deficiency in children. Semin Thromb Hemost. 2006;32:90–97.
8.
FurlanMLammleB. Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving protease. Best Pract Res Clin Haematol. 2001;14:437–454.
9.
NorisMBucchioniSGalbuseraMInternational Registry of Recurrent and Familial HUS/TTP. Complement factor H mutation in familial thrombotic thrombocytopenic purpura with ADAMTS 13 deficiency and renal involvement. J Am Soc Nephrol. 2005;16:1177–1183.
HiyamaHKusanoRMuragakiYMiuraN. Moya moya disease associated with thrombotic thrombocytopenic purpura (TTP). No Shinkei Geka. 1994;22:567–572.
12.
SinglaMJohnEHidalgoGMoya Moya vasculopathy in a child after hemolytic uremic syndrome: a possible etiopathogenesis. Neuropediatrics. 2008;39:128–130.
13.
MohrJPChoiDWGrottaJCWeirBWolfPA. Stroke: Pathophysiology, Diagnosis, and Management. 4th ed. New York: Churchill Livingstone; 2004.
14.
OberoiSBansalDSinghPMarwahaRK. Stroke in a young boy with β-thalassemia intermedia secondary to moyamoya syndrome. J Pediatr Hematol Oncol. 2010;32:568–570.
15.
ParkerTMWardLMJohnstonDLVentureyaEKlaassenRJ. A case of moyamoya syndrome and hemoglobin E/beta-thalassemia. Pediatr Blood Cancer. 2009;52:422–424.
16.
MardenFAPutmanCMGrantJMGreenbergJ. Moyamoya disease associated with hemoglobin Fairfax and beta-thalassemia. Pediatr Neurol. 2008;38:130–132.
17.
BrockmannKStolpeSFelsCKhanNKulozikAEPekrunA. Moyamoya syndrome associated with hemolytic anemia due to Hb Alesha. J Pediatr Hematol Oncol. 2005;27:436–440.
18.
Vo VanPSabouraudPMacGAbelyMBednarekN. Moyamoya disease associated with hereditary spherocytosis. Pediatr Neurol. 2011;44:69–71.
19.
SkardoutsouAVoudrisKAMastroyianniSVagiakouEMagoufisGKoukoutsakisP. Moya moya syndrome in a child with pyruvate kinase deficiency and combined prothrombotic factors. J Child Neurol. 2007;22:474–478.
